✦ LIBER ✦

DPP-4 inhibitors in the treatment of type 2 diabetes

✍ Scribed by Hélène Duez; Bertrand Cariou; Bart Staels

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Placement of DPP-4 Inhibitors in Cli

✍ Davidson, Jaime 📂 Article 📅 2013 🏛 American Association of Clinical Endocrinologists 🌐 English ⚖ 274 KB

Future perspectives for insulinotropic a

✍ B. Gallwitz; H.-U. Häring 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 583 KB

Are Sulfonylureas Less Desirable Than DP

✍ Bo Ahrén 📂 Article 📅 2011 🏛 Current Science Inc. 🌐 English ⚖ 233 KB

The oral DPP-4 inhibitor linagliptin sig

✍ T. Forst; B. Uhlig-Laske; A. Ring; A. Ritzhaupt; U. Graefe-Mody; K. A. Dugi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 578 KB

Specific actions of GLP-1 receptor agoni

✍ Stéphane Dalle; Rémy Burcelin; Pierre Gourdy 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 699 KB

The Cost-Effectiveness of Dapagliflozin

✍ Charokopou, M.; McEwan, P.; Lister, S.; Callan, L.; Bergenheim, K.; Tolley, K.; 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB